2025年6月14日 周六
Home > Archive>Volume 32, Issue 8, 2024 >705-711
PDF HTML XML Export Cite reminder
Research progress of TLR4 in acute myocardial infarction and its treatment
Author:
Affiliation:

1.Department of Laboratory Medicine, Wuhan, Hubei 430022, China;2.Research Center of Tissue Engineering and Regenerative Medicine, Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China)

Clc Number:

R5

  • Article
    • | |
  • Metrics
    • |
  • Reference [55]
    • |
  • Related [20]
    • | | |
  • Comments
    Abstract:

    Acute myocardial infarction (AMI) is a severe disease caused by the persistent coronary artery obstruction, posing a great threat to people's health. In recent years, Toll-like receptor 4 (TLR4), an important pattern recognition receptor, has been widely studied and found to play a crucial role in AMI. This review introduces the recent progress of TLR4 in regulating the progression and prognosis of AMI, and summarizes recent TLR4-targeted therapies using clinical drugs, TLR4 inhibitors, mesenchymal stem cells, and natural bioactive molecules, providing valuable insights for addressing myocardial damage caused by AMI and improving prognosis.

    Reference
    [1] 《中国心血管健康与疾病报告2022》编写组.《中国心血管健康与疾病报告2022》要点解读.中国心血管杂志, 3,8(4):297-312.Writing Committee of the Report on Cardiovascular Health and Diseases in China.Interpretation of report on cardiovascular health and diseases in China 2022.Chin J Cardiovasc Med, 3,8(4):297-312.
    [2] FUJIWARA M, MATOBA T, KOGA J I, et al.Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice.Cardiovasc Res, 9,5(7):1244-1255.
    [3] KHORRAMI A, ZIAEE M, RAMESHRAD M, et al.Oxidized cholesterol exacerbates Toll-like receptor 4 expression and activity in the hearts of rats with myocardial infarction.J Cardiovasc Thorac Res, 0,2(1):43-50.
    [4] 胡伟, 王国兵, 胡孝彬, 等.急性心肌梗死患者外周血TLR4、血清TNF-α水平变化及临床意义.中国医药导报, 9,6(1):153.HU W, WANG G B, HU X B, et al.Changes and clinical significance of TLR4 and TNF-α levels in peripheral blood of patients with acute myocardial infarction.Chin Med Her, 9,6(1):153.
    [5] LI M, CHEN F L, ZHANG Y L, et al.Identification of post-myocardial infarction blood expression signatures using multiple feature selection strategies.Front Physiol, 0,1:483.
    [6] 雷运臻, 袁正强, 李波涛, 等.Toll样受体4参与冠状动脉病变的机制及预防研究进展.中国心血管病研究, 2,0(11):1014-1019.LEI Y Z, YUAN Z Q, LI B T, et al.Research on the mechanism and the prevention of TLR4 involvement in coronary artery lesions.Chin J Cardiovasc Res, 2,0(11):1014-1019.
    [7] ISHIKAWA Y, SATOH M, ITOH T, et al.Local expression of Toll-like receptor 4 at the site of ruptured plaques in patients with acute myocardial infarction.Clin Sci (Lond), 8,5(4):133-140.
    [8] IKEJIMA H, IMANISHI T, TSUJIOKA H, et al.Upregulation of fractalkine and its receptor, CX3CR1, is associated with coronary plaque rupture in patients with unstable angina pectoris.Circ J, 0,4(2):337-345.
    [9] KASHIWAGI M, IMANISHI T, TSUJIOKA H, et al.Association of monocyte subsets with vulnerability characteristics of coronary plaques as assessed by 64-slice multidetector computed tomography in patients with stable angina pectoris.Atherosclerosis, 0,2(1):171-176.
    [10] BARILL F, CAMMISOTTO V, BARTIMOCCIA S, et al.Toll-like receptor 4 activation in platelets from myocardial infarction patients.Thromb Res, 2,9:33-40.
    [11] CARNEVALE R, SCIARRETTA S, VALENTI V, et al.Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4:implication for myocardial infarction.Eur Heart J, 0,1(33):3156-3165.
    [12] LUO J, ZHANG M Y, WANG Z X, et al.Anti-β2GPI/β2GPI induces neutrophil pyroptosis and thereby enhances ICAM-1 and IL-8 expression in endothelial cells.Int J Mol Med, 2,9(5):64.
    [13] ZHANG G T, CAI Q Q, ZHOU H, et al.OxLDL/β2GPI/anti-β2GPI Ab complex induces inflammatory activation via the TLR4/NF-κB pathway in HUVECs.Mol Med Rep, 1,3(2):148.
    [14] BEKKERING S, QUINTIN J, JOOSTEN L A B, et al.Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes.Arterioscler Thromb Vasc Biol, 4,4(8):1731-1738.
    [15] ZHANG M, XUE Y, CHEN H L, et al.Resveratrol inhibits MMP3 and MMP9 expression and secretion by suppressing TLR4/NF-κB/STAT3 activation in ox-LDL-treated HUVECs.Oxid Med Cell Longev, 9,9:9013169.
    [16] KERR N, GARCA-CONTRERAS M, ABBASSI S, et al.Inflammasome proteins in serum and serum-derived extracellular vesicles as biomarkers of stroke.Front Mol Neurosci, 8,1:309.
    [17] BIEMMI V, MILANO G, CIULLO A, et al.Inflammatory extracellular vesicles prompt heart dysfunction via TRL4-dependent NF-κB activation.Theranostics, 0,0(6):2773-2790.
    [18] TIMMERS L, SLUIJTER J P G, VAN KEULEN J K, et al.Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction.Circ Res, 8,2(2):257-264.
    [19] 周允, 卢丽霞, 魏利龙, 等.冠心病患者四种常规炎症标志物联合检测对急性心肌梗死的预测价值.中国动脉硬化杂志, 3,1(4):297-303.ZHOU Y, LU L X, WEI L L, et al.Predictive value of combined detection of four conventional inflammatory markers for acute myocardial infarction in patients with coronary heart disease.Chin J Arterioscler, 3,1(4):297-303.
    [20] SREEJIT G, ABDEL-LATIF A, ATHMANATHAN B, et al.Neutrophil-derived S100A8/A9 amplify granulopoiesis after myocardial infarction.Circulation, 0,1(13):1080-1094.
    [21] LI Y L, CHEN B Y, YANG X Y, et al.S100a8/a9 signaling causes mitochondrial dysfunction and cardiomyocyte death in response to ischemic/reperfusion injury.Circulation, 9,0(9):751-764.
    [22] KASHIWAGI M, IMANISHI T, OZAKI Y, et al.Differential expression of Toll-like receptor 4 and human monocyte subsets in acute myocardial infarction.Atherosclerosis, 2,1(1):249-253.
    [23] 杨梦, 胡思远, 李琳, 等.巨噬细胞极化在心血管疾病中的作用及中药干预研究进展.中国动脉硬化杂志, 3,1(3):261-270.YANG M, HU S Y, LI L, et al.The role of macrophage polarization in cardiovascular disease and Chinese medicine intervention.Chin J Arterioscler, 3,1(3):261-270.
    [24] DEBERGE M, GLINTON K, SUBRAMANIAN M, et al.Macrophage AXL receptor tyrosine kinase inflames the heart after reperfused myocardial infarction.J Clin Invest, 1,1(6):139576.
    [25] LI X, GUO D A, CHEN Y, et al.Toll-like receptors/TNF-α pathway crosstalk and impact on different sites of recurrent myocardial infarction in elderly patients.Biomed Res Int, 2,2:1280350.
    [26] ZHANG P, SHAO L, MA J.Toll-like receptors 2 and 4 predict new-onset atrial fibrillation in acute myocardial infarction patients.Int Heart J, 8,9(1):64-70.
    [27] CHEN X Y, ZHANG F Y, HU G Y, et al.LRRC8A critically regulates myofibroblast phenotypes and fibrotic remodeling following myocardial infarction.Theranostics, 2,2(13):5824-5835.
    [28] YANG R H, SONG Z X, WU S Q, et al.Toll-like receptor 4 contributes to a myofibroblast phenotype in cardiac fibroblasts and is associated with autophagy after myocardial infarction in a mouse model.Atherosclerosis, 8,9:23-31.
    [29] DING H S, HUANG Y, QU J F, et al.Panaxynol ameliorates cardiac ischemia/reperfusion injury by suppressing NLRP3-induced pyroptosis and apoptosis via HMGB1/TLR4/NF-κB axis.Int Immunopharmacol, 3,1:110222.
    [30] WANG X Z, YU Z X, NIE B, et al.Perindopril inhibits myocardial apoptosis in mice with acute myocardial infarction through TLR4/NF-κB pathway.Eur Rev Med Pharmacol Sci, 9,3(15):6672-6682.
    [31] CHEN F, CHEN Z Q, ZHONG G L, et al.Nicorandil inhibits TLR4/MyD88/NF-κB/NLRP3 signaling pathway to reduce pyroptosis in rats with myocardial infarction.Exp Biol Med (Maywood), 1,6(17):1938-1947.
    [32] SU Q, LV X W, SUN Y H, et al.Role of TLR4/MyD88/NF-κB signaling pathway in coronary microembolization-induced myocardial injury prevented and treated with nicorandil.Biomed Pharmacother, 8,6:776-784.
    [33] 姜晓黎, 胡昊彧, 黄玮.替格瑞洛对急性心肌梗死患者TLR4/MyD88/NF-κB信号通路的影响研究.浙江医学, 3,5(4):377-381.JIANG X L, HU H Y, HUANG W.Effects of ticagrelor on TLR4/MyD88/NF-κB signaling pathway in patients with acute myocardial infarction.Zhejiang Med J, 3,5(4):377-381.
    [34] CAO C, QI Y T, WANG A A, et al.Huoxin pill reduces myocardial ischemia reperfusion injury in rats via TLR4/NF-κB/NLRP3 signaling pathway.Chin J Integr Med, 3,9(12):1066-1076.
    [35] 陈婵, 娄洋, 吕铮天, 等.益心化浊方对急性心肌梗死后心力衰竭大鼠心肌TLR4/Treg信号通路的影响.中华中医药杂志, 1,6(8):4578-4582.CHEN C, LOU Y,Lü Z T, et al.Effects of Yixin Huazhuo formula on TLR4/Treg signaling pathway of rats with heart failure after acute myocardial infarction.China J Tradit Chin Med Pharm, 1,6(8):4578-4582.
    [36] 冯鹏飞, 郭书文, 魏路路, 等.基于TLR4/NF-κB通路研究益气活血药对心梗大鼠心室功能的影响.环球中医药, 1,4(10):1761-1766.FENG P F, GUO S W, WEI L L, et al.Effects of Yiqi Huoxue decoction on ventricular function in rats with myocardial infarction based on TLR4/NF-κB pathway.Glob Tradit Chin Med, 1,4(10):1761-1766.
    [37] 马小林, 黄政, 方存明, 等.芪苈强心胶囊通过TLR4/NF-κB通路减轻大鼠心肌炎性反应及损伤.疑难病杂志, 1,0(1):37-40.MA X L, HUANG Z, FANG C M, et al.Qiliqiangxin capsule reduces rat myocardial inflammation and damage through TLR4/NF-κB pathway.Chin J Difficult Complicat Cases, 1,0(1):37-40.
    [38] 杨梦, 胡思远, 李琳, 等.中药调控Toll样受体4信号通路干预心肌缺血作用机制研究进展.中国中医药信息杂志, 2,9(8):147-152.YANG M, HU S Y, LI L, et al.Research progress in the mechanism of TLR4 signaling pathway intervention by TCM regulation for myocardial ischemia.Chin J Inf Tradit Chin Med, 2,9(8):147-152.
    [39] FERNNDEZ G, MORAGA A, CUARTERO M I, et al.TLR4-binding DNA aptamers show a protective effect against acute stroke in animal models.Mol Ther, 8,6(8):2047-2059.
    [40] HERNNDEZ-JIMNEZ M, MARTN-VLCHEZ S, OCHOA D, et al.First-in-human phaseⅠ clinical trial of a TLR4-binding DNA aptamer, ApTOLL:safety and pharmacokinetics in healthy volunteers.Mol Ther Nucleic Acids, 2,8:124-135.
    [41] RAMIREZ-CARRACEDO R, TESORO L, HERNANDEZ I, et al.Targeting TLR4 with ApTOLL improves heart function in response to coronary ischemia reperfusion in pigs undergoing acute myocardial infarction.Biomolecules, 0,0(8):1167.
    [42] PAZ-GARCA M, POVO-RETANA A, JAN R I, et al.Beneficial effect of TLR4 blockade by a specific aptamer antagonist after acute myocardial infarction.Biomed Pharmacother, 3,8:114214.
    [43] FU H, SHUAI W, KONG B, et al.MD1 depletion predisposes to ventricular arrhythmias in the setting of myocardial infarction.Heart Lung Circ, 1,0(6):869-881.
    [44] GUO R, WAN F, MORIMATSU M, et al.Cell sheet formation enhances the therapeutic effects of human umbilical cord mesenchymal stem cells on myocardial infarction as a bioactive material.Bioact Mater, 1,6(9):2999-3012.
    [45] KADRY M O, ABDEL-MEGEED R M.Novel mesenchymal stem cell strategy in alleviating Toll-like receptor-4, p53 and Nrf2 signaling in isoproterenol-induced myocardial infarction in rat model.Cardiovasc Toxicol, 8,8(3):232-241.
    [46] SCHARY Y, ROTEM I, CALLER T, et al.CRISPR-Cas9 editing of TLR4 to improve the outcome of cardiac cell therapy.Sci Rep, 3,3(1):4481.
    [47] HAN Y Y, YANG J X, FANG J K, et al.The secretion profile of mesenchymal stem cells and potential applications in treating human diseases.Signal Transduct Target Ther, 2,7(1):92.
    [48] ZHAO J X, LI X L, HU J X, et al.Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization.Cardiovasc Res, 9,5(7):1205-1216.
    [49] MEERAN M F N, AZIMULLAH S, ADEGHATE E, et al.Nootkatone attenuates myocardial oxidative damage, inflammation, and apoptosis in isoproterenol-induced myocardial infarction in rats.Phytomedicine, 1,4:153405.
    [50] MEERAN M F N, LAHAM F, AZIMULLAH S, et al.β-caryophyllene, a natural bicyclic sesquiterpene attenuates β-adrenergic agonist-induced myocardial injury in a cannabinoid receptor-2 dependent and Independent manner.Free Radic Biol Med, 1,7:348-366.
    [51] CHAI R, YE Z, XUE W, et al.TanshinoneⅡA inhibits cardiomyocyte pyroptosis through TLR4/NF-κB p65 pathway after acute myocardial infarction.Front Cell Dev Biol, 3,1:1252942.
    [52] MI X, ZHANG Z, CHENG J, et al.Cardioprotective effects of Schisantherin A against isoproterenol-induced acute myocardial infarction through amelioration of oxidative stress and inflammation via modulation of PI3K-AKT/Nrf2/ARE and TLR4/MAPK/NF-κB pathways in rats.BMC Complement Med Ther, 3,3(1):277.
    [53] WANG L, PENG Y F, SONG L J, et al.Colchicine-containing nanoparticles attenuates acute myocardial infarction injury by inhibiting inflammation.Cardiovasc Drugs Ther, 2,6:1075-1089.
    [54] SCHATTNER M.Platelet TLR4 at the crossroads of thrombosis and the innate immune response.J Leukoc Biol, 9,5(5):873-880.
    [55] LI C F, HA T Z, KELLEY J, et al.Modulating Toll-like receptor mediated signaling by (1->3)-beta-D-glucan rapidly induces cardioprotection.Cardiovasc Res, 4,1(3):538-547.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

HU Chuting, SONG Yu, WANG Lin. Research progress of TLR4 in acute myocardial infarction and its treatment[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2024,32(8):705-711.

Copy
Share
Article Metrics
  • Abstract:171
  • PDF: 4980
  • HTML: 0
  • Cited by: 0
History
  • Received:January 24,2024
  • Revised:February 04,2024
  • Online: August 21,2024
Article QR Code

You are the 59598 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025